Avalo Therapeutics (AVTX) Revenue (2014 - 2026)
Avalo Therapeutics (AVTX) posted Revenue of $59,000 for Q4 2025, down 69.3% from $192,000 a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Revenue (2014 - 2026) Analysis & Trends
Since Q3 2016, Avalo Therapeutics has reported Revenue for 33 quarters.
- Annual Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -61.2% (FY2020 to FY2025).
- In prior years, Avalo Therapeutics' Revenue was $441,000 in FY2024 (-77.1%), $1.92 million in FY2023 (-89.3%), $18.05 million in FY2022 (+234.4%) and $5.4 million in FY2021 (-19.4%).
- The Q4 2025 figure stands as the lowest quarterly Revenue since Q4 2018.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2022, with growth of 309.1%; the weakest was Q3 2023, with a decline of 98.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - | 2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.76 Mn |
| Mar 31, 2026 | 803,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 643,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 896,000.00 |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 1.50 Mn |
API Access
Avalo Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();